The British Association for the Study of the Liver is the National Association for hepatology. BASL is dedicated to advancing knowledge and understanding of the biology and pathology of the liver for the optimal care of patients. BASL is composed of interested individuals from clinical medicine, clinical and basic research and allied professions.

The BASL umbrella incorporates four Sub-Groups and a number of Special Interest Groups:

  •  BLNA (British Liver Nurses' Association)
  •  BVHG (British Viral Hepatitis Group)
  •  BLTG (British Liver Transplant Group)
  •  BHPG (British Hepatology Pharmacy Group)

Special Interest Groups:

  • Acute liver failure
  • Alcohol related liver disease
  • Cholangiocarcinoma-UK
  • End of life
  • HBV
  • HCC-UK
  • Immune-mediated liver disease
  • Portal hypertension
  • Rare Diseases; Wilson’s Disease, Alpha-1 antitrypsin deficiency and Haemochromatosis
  • Acute on Chronic Liver Failure (including frailty and sarcopenia)

BASL aims to:

Disseminate research findings and clinical expertise in liver disease;

Promote and provide opportunities for collaboration in liver research;

Provide a voice that can advise and interact with the media to raise awareness of liver disease within the UK;

To advise policymakers within the health service how to advance the provision of care for patients with liver disease within the UK;

BASL is a not for profit Association whose income is derived from membership fees, donations and its various activities, such as the revenue of scientific meetings. Monies derived from such activities are used to support further educational events and the attendance thereto of its members.

BASL Annual Meeting:

BASL is delighted to announce that the BASL2021 Annual Meeting will take place virtually on 22-24 September 2021 and we invite authors to submit abstracts for the event.  Full information can be found on the BASL Events page of the website. Both BLTG and BLNA are planning meetings at this time too and further details will be shared once known.